An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects
Clinical trial NCT03424252 · COMPLETED
Trial details
- NCT number
- NCT03424252
- Sponsor
- Flatley Discovery Lab LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2018-01-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.